Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

433 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Brain metastases from NSCLC treated with stereotactic radiotherapy: prediction mismatch between two different radiomic platforms.
Carloni G, Garibaldi C, Marvaso G, Volpe S, Zaffaroni M, Pepa M, Isaksson LJ, Colombo F, Durante S, Lo Presti G, Raimondi S, Spaggiari L, de Marinis F, Piperno G, Vigorito S, Gandini S, Cremonesi M, Positano V, Jereczek-Fossa BA. Carloni G, et al. Radiother Oncol. 2023 Jan;178:109424. doi: 10.1016/j.radonc.2022.11.013. Epub 2022 Nov 24. Radiother Oncol. 2023. PMID: 36435336
The dosimetric impact of axillary nodes contouring variability in breast cancer radiotherapy: An AIRO multi-institutional study.
Leonardi MC, Pepa M, Luraschi R, Vigorito S, Dicuonzo S, Isaksson LJ, La Porta MR, Marino L, Ippolito E, Huscher A, Argenone A, De Rose F, Cucciarelli F, De Santis MC, Rossi F, Prisco A, Guarnaccia R, Tabarelli de Fatis P, Palumbo I, Colangione SP, Mormile M, Ravo V, Fozza A, Aristei C, Orecchia R, Cattani F, Jereczek-Fossa BA; Collaborative Italian Association of Radiotherapy and Clinical Oncology (AIRO) Breast Study Group. Leonardi MC, et al. Radiother Oncol. 2022 Mar;168:113-120. doi: 10.1016/j.radonc.2022.01.004. Epub 2022 Jan 13. Radiother Oncol. 2022. PMID: 35033602
Comparison of automated segmentation techniques for magnetic resonance images of the prostate.
Isaksson LJ, Pepa M, Summers P, Zaffaroni M, Vincini MG, Corrao G, Mazzola GC, Rotondi M, Lo Presti G, Raimondi S, Gandini S, Volpe S, Haron Z, Alessi S, Pricolo P, Mistretta FA, Luzzago S, Cattani F, Musi G, Cobelli O, Cremonesi M, Orecchia R, Marvaso G, Petralia G, Jereczek-Fossa BA. Isaksson LJ, et al. BMC Med Imaging. 2023 Feb 11;23(1):32. doi: 10.1186/s12880-023-00974-y. BMC Med Imaging. 2023. PMID: 36774463 Free PMC article.
The role of radiomics in tongue cancer: A new tool for prognosis prediction.
Mossinelli C, Tagliabue M, Ruju F, Cammarata G, Volpe S, Raimondi S, Zaffaroni M, Isaksson JL, Garibaldi C, Cremonesi M, Corso F, Gaeta A, Emili I, Zorzi S, Alterio D, Marvaso G, Pepa M, De Fiori E, Maffini F, Preda L, Benazzo M, Jereczek-Fossa BA, Ansarin M. Mossinelli C, et al. Head Neck. 2023 Apr;45(4):849-861. doi: 10.1002/hed.27299. Epub 2023 Feb 13. Head Neck. 2023. PMID: 36779382
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL.
Mazzara S, Travaini L, Botta F, Granata C, Motta G, Melle F, Fiori S, Tabanelli V, Vanazzi A, Ramadan S, Radice T, Raimondi S, Lo Presti G, Ferrari ME, Jereczek-Fossa BA, Tarella C, Ceci F, Pileri S, Derenzini E. Mazzara S, et al. Blood Adv. 2023 Feb 28;7(4):630-643. doi: 10.1182/bloodadvances.2022007825. Blood Adv. 2023. PMID: 36806558 Free PMC article.
Automatic Segmentation with Deep Learning in Radiotherapy.
Isaksson LJ, Summers P, Mastroleo F, Marvaso G, Corrao G, Vincini MG, Zaffaroni M, Ceci F, Petralia G, Orecchia R, Jereczek-Fossa BA. Isaksson LJ, et al. Cancers (Basel). 2023 Sep 1;15(17):4389. doi: 10.3390/cancers15174389. Cancers (Basel). 2023. PMID: 37686665 Free PMC article. Review.
Association between Contrast-Enhanced Computed Tomography Radiomic Features, Genomic Alterations and Prognosis in Advanced Lung Adenocarcinoma Patients.
Rinaldi L, Guerini Rocco E, Spitaleri G, Raimondi S, Attili I, Ranghiero A, Cammarata G, Minotti M, Lo Presti G, De Piano F, Bellerba F, Funicelli G, Volpe S, Mora S, Fodor C, Rampinelli C, Barberis M, De Marinis F, Jereczek-Fossa BA, Orecchia R, Rizzo S, Botta F. Rinaldi L, et al. Cancers (Basel). 2023 Sep 14;15(18):4553. doi: 10.3390/cancers15184553. Cancers (Basel). 2023. PMID: 37760521 Free PMC article.
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E2-RADIatE OligoCare cohort.
Bultijnck R, Van Hemelrijck M, Fonteyne V, Livi L, Jereczek-Fossa BA, Hemmatazad H, Mayinger M, Peulen H, Verbeke L, Ramella S, Castro P, Tsoutsou P, Stellamans K, Shaukat A, Orazem M, Jeene P, Braam P, Verkooijen H, Simek IM, Alongi F, Clementel E, Fortpied C, Machingura A, Boakye Oppong F, Guckenberger M, Ost P. Bultijnck R, et al. Clin Transl Radiat Oncol. 2023 Dec 29;45:100715. doi: 10.1016/j.ctro.2023.100715. eCollection 2024 Mar. Clin Transl Radiat Oncol. 2023. PMID: 38274388 Free PMC article.
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study.
Nicosia L, Franceschini D, Perrone-Congedi F, Molinari A, Gerardi MA, Rigo M, Mazzola R, Perna M, Scotti V, Fodor A, Iurato A, Pasqualetti F, Gadducci G, Chiesa S, Niespolo RM, Bruni A, Cappelli A, D'Angelo E, Borghetti P, Di Marzo A, Ravasio A, De Bari B, Sepulcri M, Aiello D, Mortellaro G, Sangalli C, Franceschini M, Montesi G, Aquilanti FM, Lunardi G, Valdagni R, Fazio I, Scarzello G, Vavassori V, Maranzano E, Maria Magrini S, Arcangeli S, Gambacorta MA, Valentini V, Paiar F, Ramella S, Di Muzio NG, Loi M, Jereczek-Fossa BA, Casamassima F, Osti MF, Scorsetti M, Alongi F. Nicosia L, et al. Clin Transl Radiat Oncol. 2022 Dec 20;39:100568. doi: 10.1016/j.ctro.2022.100568. eCollection 2023 Mar. Clin Transl Radiat Oncol. 2022. PMID: 36935855 Free PMC article.
433 results